We compared CSF samples from HAM and HTLV-1-uninfected non-neuroinflammatory neurological disease patients (control group) to establish cut-off values for neopterin and CXCL-10 based on ELISA tests. This evidence concerns the gene CXCL10 and tropical spastic paraparesis.